This post was originally published on this site.
Employers are facing double-digit healthcare cost increases this year, with pharmacy spending being a major contributor, according to the International Foundation of Employee Benefit Plans. GLP-1 medications, originally prescribed for Type 2 diabetes and now commonly used for weight management, are among the biggest contributors to this rising cost.
Employers are staring down double-digit healthcare cost increases this year, according to the International Foundation of Employee Benefit Plans, and pharmacy spending is a major reason why. Among the biggest contributors are GLP-1 medications, originally prescribed for Type 2 diabetes and now widely used for weight management. These drugs started
